An expert consensus to standardize definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn’s disease

BACKGROUND: Fibrotic stricture is a common complication of Crohn’s disease (CD) affecting approximately half of all patients. No specific anti-fibrotic therapies are available; however, several therapies are currently under evaluation. Drug development for the indication of stricturing CD is hampere...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Aliment Pharmacol Ther
المؤلفون الرئيسيون: Rieder, Florian, Bettenworth, Dominik, Ma, Christopher, Parker, Claire E., Williamson, Lee A., Nelson, Sigrid A., van Assche, Gert, Di Sabatino, Antonio, Bouhnik, Yoram, Stidham, Ryan W., Dignass, Axel, Rogler, Gerhard, Taylor, Stuart A., Stoker, Jaap, Rimola, Jordi, Baker, Mark E., Fletcher, Joel G., Panes, Julian, Sandborn, William J., Feagan, Brian G., Jairath, Vipul
التنسيق: Artigo
اللغة:Inglês
منشور في: 2018
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6043370/
https://ncbi.nlm.nih.gov/pubmed/29920726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14853
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة